COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,358 Articles (22,803 medRxiv, 8,555 bioRxiv)

Most recent first Previous |  Page 2525: Articles 25241-25250  | Next

Clinical Characteristics of Recurrent-positive Coronavirus Disease 2019 after Curative Discharge: a retrospective analysis of 15 cases in Wuhan China
Chen, L., Zhang, Z.-Y., Zhang, X.-B., Zhang, S.-Z., Han, Q.-Y., Feng, Z.-P., Fu, J.-G., Xiao, X., Chen, H.-M., Liu, L.-L., Chen, X.-L., Lan, Y.-P., Zhong, D.-J., Hu, L., Wang, J.-H., Yin, Z.-Y.
10.1101/2020.07.02.20144873 — Posted: 2020-07-04
A systematic review of the smartphone applications available for coronavirus disease 2019 (COVID19) and their assessment using the mobile app rating scale (MARS)
Davalbhakta, S., Advani, S., Kumar, S., Agarwal, V., Bhoyar, S., Fedirko, E., Misra, D., Goel, A., Gupta, L., Agarwal, V.
10.1101/2020.07.02.20144964 — Posted: 2020-07-04
Tissue-specific tolerance in fatal Covid-19
Dorward, D. A., Russell, C. D., Um, I. H., Elshani, M., Armstrong, S. D., Penrice-Randal, R., Millar, T., Lerpiniere, C. E., Tagliavini, G., Hartley, C. S., Randall, N. P., Gachanja, N. N., Potey, P. M., Anderson, A. M., Campbell, V. L., Duguid, A. J., Al Qsous, W., BouHaidar, R., Baillie, J. K., Dhaliwal, K., Wallace, W. A., Bellamy, C. O., Prost, S., Smith, C., Hiscox, J. A., Harrison, D. J., Lucas, C. D., ICECAP
10.1101/2020.07.02.20145003 — Posted: 2020-07-04 Discussion: Onsite
Metabolic indicators associated with non-communicable diseases deteriorated in COVID-19 outbreak: evidence from a two-center, retrospective study
Xue, T., Xu, L., yaqian, m., Lin, W., Liang, J., Huang, H., Li, L., Wen, J., Chen, G.
10.1101/2020.07.02.20144857 — Posted: 2020-07-04
Curve-fitting approach for COVID-19 data and its physical background
Nishimoto, Y., Inoue, K.
10.1101/2020.07.02.20144899 — Posted: 2020-07-04
Psychiatric symptoms, risk, and protective factors among university students in quarantine during the COVID-19 pandemic in China
Sun, S., Goldberg, S. B., Lin, D., Qiao, S., Operario, D.
10.1101/2020.07.03.20144931 — Posted: 2020-07-04
The projected impact of mitigation and suppression strategies on the COVID-19 epidemic in Senegal: A modelling study
Thompson, H. A., Mboup, A., Cisse, B., Nayagam, S., Watson, O. J., Whittaker, C., Walker, P. G. T., Ghani, A. C., Mboup, S.
10.1101/2020.07.03.20144949 — Posted: 2020-07-04
Prevalence of IgG and IgM antibodies to SARS-CoV-2 among clinic staff and patients
Asuquo, M. I., Effa, E., Otu, A., Ita, O., Udoh, U., Umoh, V., Gbotosho, O., Ikpeme, A., Ameh, S., Egbe, W., Etok, M., Ekpenyong, A., Guck, J.
10.1101/2020.07.02.20145441 — Posted: 2020-07-04
Increasing Virus Test Capacity via Recursive Pool Testing with an Application to SARS-CoV-2 Testing
Mutzel, P., Bertram, A., Jünger, P., Jünger, P., Krieger, H., Schmitz, S., Jünger, M.
10.1101/2020.07.02.20144956 — Posted: 2020-07-04
Battle with COVID-19 Under Partial to Zero Lockdowns in India
Babbar, S.
10.1101/2020.07.03.20145664 — Posted: 2020-07-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).